SCHEMBL19185191

SCHEMBL19185191

COc1ccc(CNc2nc(C(C)C)c3ncccc3n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.52
CCNE1 P24864 1/20 0.48
CDK2 P24941 1/20 0.48
CDK5 Q00535 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
NPC1 O15118 1/20 0.45
EGFR P00533 1/20 0.44
POLB P06746 1/20 0.44
NR2F2 P24468 1/20 0.44
EGLN1 Q9GZT9 1/20 0.44
SLC2A1 P11166 1/20 0.43
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
CLK4 Q9HAZ1 3/20 0.43
DYRK1A Q13627 2/20 0.42
PDE2A O00408 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14666992 0.86 APP (0.49) APPCCNE1CDK2CDK5NPC1
SCHEMBL16541503 0.84 APP (0.55) APPNPC1EGFRPOLBNR2F2
SCHEMBL14666993 0.75 PRMT5 (0.38) TDP1LMNATP53
SCHEMBL5622343 0.74 VNN1 (0.59) APPNPC1EGFRPOLBNR2F2
SCHEMBL11973260 0.74 EGFR (0.51) APPNPC1EGFRPOLBNR2F2
SCHEMBL14670848 0.72 PRMT5 (0.38) TDP1NPC1LMNATP53
SCHEMBL30996045 0.72 MAPT (0.62) NPC1EGLN1LMNATP53
SCHEMBL15900574 0.71 NPC1 (0.58) APPCCNE1CDK2TDP1NPC1
SCHEMBL84029 0.70 CLK4 (0.57) TDP1CCNB2CDK1CCNB1CCNB3
SCHEMBL5823848 0.70 APP (0.60) APPEGFRPOLBNR2F2SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9718815-B2 Heterocyclic compounds and uses thereof INFINITY PHARMACEUTICALS, INC. (US) 2017-08-01 US disclosed